Telavancin Pediatric PK Study (Ages >12 Months to 17 Years)

Clinical trial NCT02013141 · TERMINATED

Trial details

NCT number: NCT02013141
Sponsor: Cumberland Pharmaceuticals
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Gram-Positive Bacterial Infections

Start date: 2014-12-01
Primary completion: 2021-03-01
Enrollment: 22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.